Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

8 Aug 2008 07:00

RNS Number : 9193A
Avon Rubber PLC
08 August 2008
 



 8th August 2008

AVON RUBBER p.l.c.

("Avon", the "Group" or the "Company")

Interim Management Statement for the period from 31 March 2008 to 7 August 2008

In the interim results announced on 28 May 2008, the Company stated that the award of the multi-year respirator contract by the US Department of Defense (DoD) and the expectation of securing long-term contracts for the Engineered Fabrications business, should underpin the Group's return to profitability in the short-term. It was further explained that difficulties had been experienced in the production of filters for the M50 respirator, which had led to delays and cost overruns. 

Avon has now commenced delivery to schedule of mask systems against the DoD order, but has experienced continuing start up production issues relating to these complex new filters which will restrict our ability to deliver accelerated quantities of systems this financial year. Avon is confident that measures have been implemented to resolve these issues. However, production costs, as a consequence, will be higher in the current financial year.

The Company is also pleased to announce that the DoD has exercised a requirements option under our contract which allows theto order total quantities of up to 300,000 mask systems per year for a period of up to 10 years. Orders of $17are expected to be placed under this contract for delivery next year in addition to the $22m already on order.

Delays in the award of a multi-year Government contract to our US based Engineered Fabrications business will reduce its revenue this financial year. The Company remains confident that this contract will be in place for 2009. At Avon-ISI, the improved levels of enquiries and orders experienced towards the end of the first half have not been maintained, largely due to aggressive market pricing by competitors. We are taking actions to manage this situation. 

Net debt increased to £18.3m at 30 June 2008 (31 March 2008: £13.5m) due to costs associated with the closure of the mixing plant and a further increase in working capital associated with the DoD contract. 

The excellent performance from the Dairy business has continued. The Company believes that the Protection and Defense business with its range of new products, the orders currently in hand and the future opportunities arising from our unique market position will deliver significantly enhanced future performance. 

Peter Slabbert, recently appointed as Chief Executive, commented:

"We have strengthened the management team with the appointment of Andrew Lewis as Group Finance Director and Matthew Evans from BAE Systems, as Rest of World Sales and Marketing Director within the Protection business and we are actively pursuing all opportunities for returning the Group to profitability."

END >

For further enquiries please contact: 

Avon Rubber p.l.c:

Peter Slabbert  01225 896883

Weber Shandwick Financial:

Richard Hews

Rachel Martin 020 7067 0700

Hannah Marwood

NOTES TO EDITORS:

Avon Rubber p.l.c. is an international polymer engineering group adding value through material, manufacturing and industry sector expertise. For further information please visit the Group's website www.avon-rubber.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSWFMWSASEEA
Date   Source Headline
27th Sep 20077:01 amRNSAppointments
14th Sep 20077:00 amRNSMoU for Turkish Supply
3rd Sep 200710:30 amRNSTotal Voting Rights
21st Aug 20071:39 pmRNSHolding(s) in Company
3rd Aug 200710:04 amRNSHolding(s) in Company
1st Aug 20072:06 pmRNSTotal Voting Rights
29th Jun 200711:49 amRNSTotal Voting Rights
19th Jun 20077:01 amRNSShare Ownership Trust
18th Jun 20071:42 pmRNSHolding(s) in Company
13th Jun 20074:09 pmRNSShare Ownership Trust
1st Jun 200710:02 amRNSTotal Voting Rights
31st May 20077:02 amRNSInterim Report
17th May 20077:01 amRNSInterim Results
17th May 20077:01 amRNSBoard Appointment
1st May 20079:42 amRNSTotal Voting Rights
30th Apr 20074:36 pmRNSNotice of Results
25th Apr 20079:29 amRNSBlocklisting Interim Review
5th Apr 20074:15 pmRNSHolding(s) in Company
4th Apr 20076:03 pmRNSHolding(s) in Company
2nd Apr 20077:02 amRNSTrading Update
30th Mar 20072:17 pmRNSHolding(s) in Company
16th Mar 200710:10 amRNSHolding(s) in Company
13th Mar 20073:26 pmRNSHolding(s) in Company
9th Mar 200712:59 pmRNSHolding(s) in Company - Amend
8th Mar 20072:45 pmRNSHolding(s) in Company
1st Mar 20079:08 amRNSTotal Voting Rights
6th Feb 200712:41 pmRNSManagement Change
6th Feb 20079:48 amRNSAdditional Listing
1st Feb 20072:41 pmRNSTotal Voting Rights
30th Jan 20071:03 pmRNSHolding(s) in Company
25th Jan 200712:30 pmRNSAnnual General Meeting
25th Jan 20077:01 amRNSAGM Statement
19th Jan 200711:29 amRNSHolding(s) in Company
18th Jan 200711:46 amRNSTotal Voting Rights
12th Jan 200710:00 amRNSAnnual Information Update
5th Jan 200712:51 pmRNSDirector/PDMR Shareholding
3rd Jan 20074:20 pmRNSHolding(s) in Company
22nd Dec 20068:31 amRNSAnnual Report and Accounts
20th Dec 20063:05 pmRNSDirector/PDMR Shareholding
19th Dec 20062:54 pmRNSHolding(s) in Company
14th Dec 200610:55 amRNSDirector/PDMR Shareholding
14th Dec 200610:05 amRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSBoard Changes
12th Dec 20062:27 pmRNSHolding(s) in Company
8th Dec 20064:27 pmRNSTotal Voting Rights
5th Dec 200612:12 pmRNSHolding(s) in Company
1st Dec 20062:24 pmRNSDividend Declaration
30th Nov 20067:03 amRNSFinal Results
7th Nov 20061:01 pmRNSNotice of Results
1st Nov 20062:07 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.